On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

Author： Ponomarenko N. A.   Durova O. M.   Vorob'ev I. I.   Suchkov S. V.   Gabibov A. G.  

Publisher： MAIK Nauka/Interperiodica

ISSN： 1607-6729

Source： Doklady Biochemistry & Biophysics, Vol.395, Iss.1-6, 2004-03, pp. : 120-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does catalytic activity of bence-jones proteins contribute to the pathogenesis of multiple myeloma?

By Sinohara Hyogo   Matsuura Kinji  

Applied Biochemistry and Biotechnology, Vol. 83, Iss. 1-3, 2000-01 ,pp. : 85-94

Humana Press, Inc

Access to resources Recommend Favorite

Substrate specificity of catalytic autoantibodies in neurodegenerative processes

By Belogurov A.   Kurkova I.   Misikov V.   Suchkov S.   Telegin G.   Alekhin A.   Goncharov N.   Knorre V.   Gabibov A.   Ponomarenko N.  

Doklady Biochemistry & Biophysics, Vol. 413, Iss. 1, 2007-04 ,pp. : 61-64

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Tovaxin for multiple sclerosis

By Rivera Victor M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar   J Steven Alexander   Mohammad Ali Sahraian   Robert Zivadinov  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite